Pharmac’s specialist advisory committees provide Pharmac with objective specialist knowledge and expertise within specific clinical areas, such as diabetes, cancer, and mental health. They meet as ...

Pharmac has secured additional stock of the Epilim 100 mg crushable tablets. This will ensure supply of this medicine until the end of 2027. Our initial advice was that stock would run out by November ...

The Prescription for Pharmacoeconomic Analysis (PFPA) is a guide for anyone assessing the value for money of pharmaceuticals in New Zealand. The intention is that funding proposals can be assessed to ...

Pharmacists, a brand switch fee has been approved by Health NZ. It will run for three months and will likely apply from 1 April 2027. Your original version of ...

Due to an issue at the manufacturing plant, there is a supply issue affecting the 25 mg and 50 mg strengths of Vedafil brand sildenafil. Sildenafil is funded for a small number of reasons, including ...

Register for supplier briefing An online supplier briefing will be held online at 1:00 pm New Zealand Daylight Time (NZDT) on 16 July 2026. If you are interested in attending this, please register ...

Why is this happening This is a tender brand change. Every year, Pharmac runs a tender process to create competition among suppliers to supply many medicines used by New Zealanders. The tender helps ...

Advisory meeting agenda setting The scheduling and agenda setting process for advisory meetings considers multiple factors. We aim to balance the relative priorities of clinical advice needed across ...

What are the priority lists? There will always be more medicines and related products that we want to fund than we can afford. To help us decide which to fund first, we organise the funding ...

New Pharmacode funded from 12 June 2026 As soon as we learned of the supply problem, Pharmac acted quickly to list the new Pharmacode. It was funded from 12 June 2026. Unfortunately, the system does ...

Advisory meeting agenda setting The scheduling and agenda setting process for advisory meetings considers multiple factors. We aim to balance the relative priorities of clinical advice needed across ...

What we’re doing We're pleased to announce the approval of a listing agreement with Thermo Fisher Scientific New Zealand Limited (“Thermo Fisher Scientific”) for the supply of laboratory equipment and ...